First Report of Columbia Root Knot Nematode (\u3ci\u3eMeloidogyne chitwoodi\u3c/i\u3e) in Potato in Texas

Columbia root-knot nematode, Meloidogyne chitwoodi Golden et al. (1) was identified from potatoes, Solanum tuberosum L., collected from Dallam County, Texas in October 2000. Seed potatoes are the most likely source for this introduction. This nematode is currently found infecting potatoes grown in California, Colorado, Idaho, New Mexico, Nevada, Oregon, Utah, and Washington. Some countries prohibit import of both seed and table stock potatoes originating in states known to harbor M. chitwoodi. Lesions on the potatoes had discrete brown coloration with white central spots in the outer 1 cm of the tuber flesh. Female nematode densities averaged 3 per square centimeter of a potato section beneath the lesions. Nematodes were morphologically identified as M. chitwoodi based on the perineal pattern of mature females and the tail shape of juveniles per Golden et al. (1)

First record of Reticulitermes flavipes (Isoptera: Rhinotermitidae) from Terceira Island (Azores, Portugal)

Copyright © 2012 Florida Entomological Society.Reticulitermes flavipes, a Holarctic pestiferous subterranean termite species, particularly to structures and non-indigenous trees, is reported for the first time from Terceira Island, Azores, Portugal. The establishment of R. flavipes on Terceira Island likely represents more than one anthropogenic introduction with a high probability of military involvement

Phylogeography and population genetics of honey bees (Apis mellifera) from Turkey based on COI-COII sequence data

A study that involved DNA sequencing of COI-COII intergenic region of the mitochondrial DNA genome of Apis mellifera honey bees from Turkey was conducted to determine the population genetics and phylogeographic structure of this species from seven distinct areas of Turkey. From the 132 honey bees subjected to DNA sequencing, a total of 12 mitotypes of A. mellifera "C" lineage were observed, of which only one mitotype, C 13, had been reported previously. The most common mitotype, C12, accounted for 47% of the Apis mellifera "C" lineage samples and was found in 13 of the 22 sampled locations. This mitotype was also the basal ancestral mitotype based on TCS spanning tree analysis. The greatest amount of genetic diversity was observed in Bursa, where 4 mitotypes of the A. mellifera "C" lineage were unique to this location. Wright's F-statistics revealed that Artvin and Bursa were the most genetically distinct locations relative to the other sampled locations. Applying a molecular clock, Turkish A. mellifera "C" lineage mitotypes have been diverging for approximately 10,000 to 16,500 yr. based on phylogenetic analysis. In addition, two A. m. syriaca samples were observed from Hatay, Turkey. Phylogenetic analysis which included other A. mellifera subspecies confirms the subspecies relationships of A. mellifera "C" lineage, and A. m. syriaca. this study corroborates other studies that show Turkey to be a reservoir of genetically distinct populations of A. mellifera "C" lineage, which can be useful for developing genetic conservation strategies for A. mellifera

Decisions at the end of life: have we come of age?

Decision making is a complex process and it is particularly challenging to make decisions with, or for, patients who are near the end of their life. Some of those challenges will not be resolved - due to our human inability to foresee the future precisely and the human proclivity to change stated preferences when faced with reality. Other challenges of the decision-making process are manageable. This commentary offers a set of approaches which may lead to progress in this field

Barriers and enablers in the management of tuberculosis treatment in Addis Ababa, Ethiopia: a qualitative study

Tuberculosis (TB) is an infectious disease which causes about two million deaths each year. In 1993, the World Health Organization (WHO) declared TB to be a “Global Emergency” due to an increasing number of TB cases and a rise in multidrug resistant cases in the developed world. Treatment interruption was considered one of the major challenges. WHO introduced the current TB control program DOTS (directly observed treatment, short course) as the tool to control the disease. To prevent further development of resistance against anti-TB drugs it was decided to observe each patient taking their daily dose of medication. The overall aim of this thesis is to explore how patients and health workers perceive and manage TB symptoms and treatment in a high-endemic and a low-endemic setting in the era of DOT(S). The data is based on fieldwork, including in-depth interviews and focus groups with TB patients and health workers, in Addis Ababa, Ethiopia (2001-2002) and in Oslo/Akershus, Norway (2007-2008). We found that people’s interpretation and management of TB symptoms is influenced by cultural, social and economic factors. TB was, in both contexts, associated with poverty, and subsequently with a disease that affects certain countries or certain segments of a population. TB was viewed as a severe disease in both contexts, but there was variation between individuals to what extent one considered oneself as a likely victim. In the absence of circumstantial causes, such as poverty, patients in a lowendemic setting like Norway, found it difficult to understand why they had developed the disease. There was scarce knowledge about the fact that the disease could be latent. Awareness of early symptoms, such as persistent cough, was low in both contexts. Perceptions of vulnerability, together with the presence or absence of socio-economic barriers or enablers influenced at what time patients would seek help. The study suggests that health personnel lacked awareness or misinterpreted early symptoms of TB. In Ethiopia, lay categorizations of early TB symptoms converged with diagnostic practices in parts of the professional health sector. The diagnostic process could endure for many months after patients’ first contact with the health services. Similarly, in Norway, we found that patients’ interpretations of early symptoms often were confirmed in the meeting with health personnel. The consequences were prolonged diagnostic processes. The study shows that patients’ ability to manage TB treatment is a product of dynamic processes, in which social and economic costs and other burdens interplay over time. A decision to interrupt treatment can be shaped by past struggles and accrued costs; in which seems financially, socially or emotionally unbearable at the moment of treatment interruption. The burdens related to DOT could also be significant, in patients who did not interrupt treatment. Patients in both Ethiopia and Norway experienced an authoritarian and rigid practice of DOT, which made it difficult to simultaneously attend to demands related to treatment and demands related to other areas of life. The most vulnerable patients, such as those without permanent jobs, suffered from high economic, social and emotional costs. In conclusion, health personal need more knowledge about typical and atypical symptoms of TB. In low-endemic settings doctors need to be trained to adjust their level of suspicion to the migration history of the patient. In high-endemic settings one should be aware that health personnel may understand and manage TB within a traditional perspective. Patients in both high- and low-endemic contexts need concrete information about the cause of TB, how it is transmitted, how symptoms can be manifested, how the disease can progress and how it can be cured. The study indicates that inequalities that predispose for TB may be reinforced in the patient’s interaction with the health services due to a rigid, disempowering practice of DOT. Subsequently, DOT per se may add to the chain of structural barriers that patients have to overcome to access and complete treatment. To ensure that TB patients complete treatment one must address the coexisting and interacting crises that follow a TB diagnosis. This could require TB programs to adopt a more holistic approach. Measures that secure early diagnosis may reduce some of the physical, psycho-social and economic costs patients face while undergoing treatment. Measures that empower patients to participate in their own health care may avoid disempowering and humiliating practices